10.53 USD
+0.29 (+2.83%)
10.53 USD
0 (0%)
Overall JYNT gets a fundamental rating of 4 out of 10. We evaluated JYNT against 100 industry peers in the Health Care Providers & Services industry. While JYNT has a great health rating, there are worries on its profitability. JYNT has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- JYNT had negative earnings in the past year.
- In the past year JYNT had a positive cash flow from operations.
- In multiple years JYNT reported negative net income over the last 5 years.
- Each year in the past 5 years JYNT had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of JYNT (-1.40%) is comparable to the rest of the industry.
- With a Return On Equity value of -4.27%, JYNT perfoms like the industry average, outperforming 47.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.4% | ||
| ROE | -4.27% | ||
| ROIC | N/A |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- JYNT has a Gross Margin of 78.26%. This is amongst the best in the industry. JYNT outperforms 93.00% of its industry peers.
- In the last couple of years the Gross Margin of JYNT has declined.
- JYNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.26% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
2. Health
2.1 Basic Checks
- JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, JYNT has more shares outstanding
- Compared to 5 years ago, JYNT has more shares outstanding
- There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- JYNT has an Altman-Z score of 3.13. This indicates that JYNT is financially healthy and has little risk of bankruptcy at the moment.
- JYNT's Altman-Z score of 3.13 is fine compared to the rest of the industry. JYNT outperforms 65.00% of its industry peers.
- There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.13 |
ROIC/WACCN/A
WACC8.91%
2.3 Liquidity
- A Current Ratio of 1.83 indicates that JYNT should not have too much problems paying its short term obligations.
- With a decent Current ratio value of 1.83, JYNT is doing good in the industry, outperforming 73.00% of the companies in the same industry.
- JYNT has a Quick Ratio of 1.83. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.
- With a decent Quick ratio value of 1.83, JYNT is doing good in the industry, outperforming 76.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 99.03% over the past year.
- The Revenue for JYNT has decreased by -24.15% in the past year. This is quite bad
- Measured over the past years, JYNT shows a small growth in Revenue. The Revenue has been growing by 1.36% on average per year.
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
3.2 Future
- Based on estimates for the next years, JYNT will show a very strong growth in Earnings Per Share. The EPS will grow by 44.54% on average per year.
- JYNT is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -22.13% yearly.
EPS Next Y84.93%
EPS Next 2Y105.18%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue Next Year-54.7%
Revenue Next 2Y-30.66%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- JYNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- The Price/Forward Earnings ratio is 21.66, which indicates a rather expensive current valuation of JYNT.
- JYNT's Price/Forward Earnings is on the same level as the industry average.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.31, JYNT is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 21.66 |
4.2 Price Multiples
- The rest of the industry has a similar Price/Free Cash Flow ratio as JYNT.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 95.91 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as JYNT's earnings are expected to grow with 44.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y105.18%
EPS Next 3Y44.54%
5. Dividend
5.1 Amount
- No dividends for JYNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
10.53
+0.29 (+2.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-11 2026-03-11/amc
Inst Owners78.47%
Inst Owner Change0%
Ins Owners22.97%
Ins Owner Change2.21%
Market Cap156.58M
Revenue(TTM)91.63M
Net Income(TTM)-970.20K
Analysts76
Price Target10.97 (4.18%)
Short Float %7.28%
Short Ratio7.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.07%
Min Revenue beat(2)-2.34%
Max Revenue beat(2)-1.81%
Revenue beat(4)0
Avg Revenue beat(4)-14.21%
Min Revenue beat(4)-51.14%
Max Revenue beat(4)-1.53%
Revenue beat(8)3
Avg Revenue beat(8)-6.24%
Revenue beat(12)3
Avg Revenue beat(12)-4.83%
Revenue beat(16)5
Avg Revenue beat(16)-4.04%
PT rev (1m)0%
PT rev (3m)-27.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-1200%
Revenue NQ rev (1m)-1.72%
Revenue NQ rev (3m)-7.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 21.66 | ||
| P/S | 1.71 | ||
| P/FCF | 95.91 | ||
| P/OCF | 50.98 | ||
| P/B | 6.9 | ||
| P/tB | 6.9 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.01
EYN/A
EPS(NY)0.49
Fwd EY4.62%
FCF(TTM)0.11
FCFY1.04%
OCF(TTM)0.21
OCFY1.96%
SpS6.16
BVpS1.53
TBVpS1.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.4% | ||
| ROE | -4.27% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.26% | ||
| FCFM | 1.78% |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
F-Score6
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 78.79% | ||
| Cap/Sales | 1.57% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 3.13 |
F-Score6
WACC8.91%
ROIC/WACCN/A
Cap/Depr(3y)57.36%
Cap/Depr(5y)93.23%
Cap/Sales(3y)6.25%
Cap/Sales(5y)6.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
EPS Next Y84.93%
EPS Next 2Y105.18%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
Revenue Next Year-54.7%
Revenue Next 2Y-30.66%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A
EBIT growth 1Y-575.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year312.75%
EBIT Next 3Y60.95%
EBIT Next 5YN/A
FCF growth 1Y-85.24%
FCF growth 3Y6.31%
FCF growth 5Y15.29%
OCF growth 1Y-81.35%
OCF growth 3Y-12.05%
OCF growth 5Y4.6%
JOINT CORP/THE / JYNT FAQ
What is the ChartMill fundamental rating of JOINT CORP/THE (JYNT) stock?
ChartMill assigns a fundamental rating of 4 / 10 to JYNT.
Can you provide the valuation status for JOINT CORP/THE?
ChartMill assigns a valuation rating of 3 / 10 to JOINT CORP/THE (JYNT). This can be considered as Overvalued.
How profitable is JOINT CORP/THE (JYNT) stock?
JOINT CORP/THE (JYNT) has a profitability rating of 3 / 10.
How financially healthy is JOINT CORP/THE?
The financial health rating of JOINT CORP/THE (JYNT) is 7 / 10.